Your session is about to expire
← Back to Search
Teleophthalmology for Diabetic Retinopathy
N/A
Waitlist Available
Led By Yao Liu, MD, MS
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 months, 36 months, 48 months
Awards & highlights
Study Summary
This trial tests if an implementation program can increase diabetic eye screening rates using teleophthalmology in rural health systems, with 10 systems and 10,000 patients taking part.
Who is the study for?
This trial is for rural health systems that already have a teleophthalmology program for diabetic eye screening but with less than 50% screening rates. These systems must serve patients in areas defined as rural and agree to share de-identified patient data.Check my eligibility
What is being tested?
The I-SITE program aims to improve diabetic eye screening rates using teleophthalmology in rural health settings. The study will involve up to 10,000 patients and 100 clinical staff across multiple sites over a period of up to 48 months.See study design
What are the potential side effects?
Since this trial focuses on the implementation of a service (teleophthalmology) rather than a medical treatment, traditional side effects are not applicable. However, there may be technical issues or challenges in data management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 months, 36 months, 48 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 months, 36 months, 48 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Patients Who Complete Annual Diabetic Eye Screening
Secondary outcome measures
Change in Proportion of Patients Who Complete Annual Diabetic Eye Screening
Eye
Identification of workflow strategies, organizational factors, and implementation components that distinguish between health systems with high and low teleophthalmology use
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Up to 10 rural health systems will be participating in I-SITE implementation with cluster-randomization of the order of initiation for the intervention. All sites will receive usual care teleophthalmology prior to I-SITE implementation.
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,377 Total Patients Enrolled
5 Trials studying Diabetic Retinopathy
9,762 Patients Enrolled for Diabetic Retinopathy
National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,401,918 Total Patients Enrolled
50 Trials studying Diabetic Retinopathy
42,935 Patients Enrolled for Diabetic Retinopathy
Yao Liu, MD, MSPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
3,526 Total Patients Enrolled
2 Trials studying Diabetic Retinopathy
3,526 Patients Enrolled for Diabetic Retinopathy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My health system offers diabetic eye screening via telehealth.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings in this clinical trial for participants?
"The trial in question, which was initially posted on March 28th 2023, does not appear to be actively recruiting patients. Nevertheless, there are 69 other clinical trials searching for participants at the present time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger